Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model

References

• Jameson J, Loscalzo J. Harrison’s Nephrology and Acid-Base Disorders, 2e. McGraw-Hill Education; 2013.
   Google Scholar
• Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician. 2008;78(6):743–750.
   PubMed Web of Science ®Google Scholar
• Choudhury D, Ahmed Z. Drug-associated renal dysfunction and injury. Nat Rev Nephrol. 2006;2(2):80.
   Web of Science ®Google Scholar
• Schissler MM, Zaidi S, Kumar H, Deo D, Brier ME, McLeish KR. Characteristics and outcomes in community-acquired versus hospital-acquired acute kidney injury. Nephrology. 2013;18(3):183–187. doi:10.1111/nep.12036
   Web of Science ®Google Scholar
• Khan S, Loi V, Rosner MH. Drug-induced kidney injury in the elderly. Drugs Aging. 2017;34(10):729–741. doi:10.1007/s40266-017-0484-4
   PubMed Web of Science ®Google Scholar
• Kino T, Hatanaka H, Hashimoto M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo). 1987;40(9):1249–1255. doi:10.7164/antibiotics.40.1249
   PubMed Web of Science ®Google Scholar
• Fung JJ. Tacrolimus and transplantation: a decade in review. Transplantation. 2004;77(9 Suppl):S41–S43. doi:10.1097/01.TP.0000126926.61434.A5
   PubMed Web of Science ®Google Scholar
• Nankivell BJ, P’Ng CH, O’Connell PJ, Chapman JR. Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: comparison of cyclosporine and tacrolimus eras. Transplantation. 2016;100(8):1723–1731. doi:10.1097/TP.0000000000001243
   PubMed Web of Science ®Google Scholar
• Liu YJ, Zhan J, Liu XL, Wang Y, Ji J, He QQ. Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Clin Nutr. 2014;33(1):59–63. doi:10.1016/j.clnu.2013.03.011
   PubMed Web of Science ®Google Scholar
• Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients. 2010;2(12):1231–1246. doi:10.3390/nu2121231
   PubMed Web of Science ®Google Scholar
• Liu RH. Health-promoting components of fruits and vegetables in the diet. Adv Nutr. 2013;4(3):384S–392S. doi:10.3945/an.112.003517
   PubMed Web of Science ®Google Scholar
• Yang R-Y, Lin S, Kuo G. Content and distribution of flavonoids among 91 edible plant species. Asia Pac J Clin Nutr. 2008;17(S1):275–279.
   Google Scholar
• Haytowitz DB, Wu X, Bhagwat S USDA database for the flavonoid content of selected foods, release 3.3. 2018.
   Google Scholar
• Kaempferol:Chemical-Structure.4444395. Royal society of chemistry. 2020. Available from: http://www.chemspider.com/Chemical-Structure.4444395.html. Accessed June 19, 2020.
   Google Scholar
• Calderon-Montano JM, Burgos-Moron E, Perez-Guerrero C, Lopez-Lazaro M. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem. 2011;11(4):298–344. doi:10.2174/138955711795305335
   PubMed Web of Science ®Google Scholar
• Chen AY, Chen YC. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem. 2013;138(4):2099–2107. doi:10.1016/j.foodchem.2012.11.139
   PubMed Web of Science ®Google Scholar
• Devi KP, Malar DS, Nabavi SF, et al. Kaempferol and inflammation: from chemistry to medicine. Pharmacol Res. 2015;99:1–10. doi:10.1016/j.phrs.2015.05.002
   PubMed Web of Science ®Google Scholar
• Rusnak F, Mertz P. Calcineurin: form and function. Physiol Rev. 2000;80(4):1483–1521. doi:10.1152/physrev.2000.80.4.1483
   PubMed Web of Science ®Google Scholar
• Musson RE, Smit NP. Regulatory mechanisms of calcineurin phosphatase activity. Curr Med Chem. 2011;18(2):301–315. doi:10.2174/092986711794088407
   PubMed Web of Science ®Google Scholar
• Klee CB, Yang S-A. Chapter 90 - calcineurin. In: Bradshaw RA, Dennis EA, editors. Handbook of Cell Signaling (Second Edition). San Diego: Academic Press; 2010:705–710.
   Google Scholar
• Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27. doi:10.4103/0976-0105.177703
   PubMedGoogle Scholar
• Iwasaki K. Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab Pharmacokinet. 2007;22(5):328–335. doi:10.2133/dmpk.22.328
   PubMed Web of Science ®Google Scholar
• Shiraga T, Matsuda H, Nagase K, et al. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. Biochem Pharmacol. 1994;47(4):727–735. doi:10.1016/0006-2952(94)90136-8
   Web of Science ®Google Scholar
• Schutte-Nutgen K, Tholking G, Suwelack B, Reuter S. Tacrolimus - pharmacokinetic considerations for clinicians. Curr Drug Metab. 2018;19(4):342–350. doi:10.2174/1389200219666180101104159
   PubMed Web of Science ®Google Scholar
• Vanhove T, Annaert P, Kuypers DRJ. Clinical determinants of calcineurin inhibitor disposition: a mechanistic review. Drug Metab Rev. 2016;48(1):88–112. doi:10.3109/03602532.2016.1151037
   PubMed Web of Science ®Google Scholar
• Qian YS, Ramamurthy S, Candasamy M, Shadab M, Kumar RH, Meka VS. Production, characterization and evaluation of kaempferol nanosuspension for improving oral bioavailability. Curr Pharm Biotechnol. 2016;17(6):549–555. doi:10.2174/1389201017666160127110609
   PubMed Web of Science ®Google Scholar
• Patel J, Buddha B, Dey S, Pal D, Mitra AK. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Am J Ther. 2004;11(4):262–277. doi:10.1097/01.mjt.0000101827.94820.22
   PubMedGoogle Scholar
• Chae YJ, Cho KH, Yoon IS, et al. Vitamin D receptor-mediated upregulation of CYP3A4 and MDR1 by quercetin in caco-2 cells. Planta Med. 2016;82(1–2):121–130.
   Web of Science ®Google Scholar
• Li C, Li X, Choi J-S. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats. Arch Pharm Res. 2009;32(1):133–138. doi:10.1007/s12272-009-1127-z
   PubMed Web of Science ®Google Scholar
• Pal D, Mitra AK. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci. 2006;78(18):2131–2145. doi:10.1016/j.lfs.2005.12.010
   PubMed Web of Science ®Google Scholar
• Sikma MA, van Maarseveen EM, van de Graaf EA, et al. Pharmacokinetics and toxicity of tacrolimus early after heart and lung transplantation. Am J Transplant. 2015;15(9):2301–2313.
   PubMed Web of Science ®Google Scholar
• Vandenbussche C, Van der Hauwaert C, Dewaeles E, et al. Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation. Arch Toxicol. 2018;92(4):1539–1550.
   PubMed Web of Science ®Google Scholar
• Al-Harbi NO, Imam F, Al-Harbi MM, et al. Treatment with aliskiren ameliorates tacrolimus-induced nephrotoxicity in rats. J Renin-Angio Aldo Syst. 2015;16(4):1329–1336. doi:10.1177/1470320314530178
   PubMed Web of Science ®Google Scholar
• Randhawa PS, Starzl TE, Demetris AJ. Tacrolimus (FK506)-associated renal pathology. Adv Anat Pathol. 1997;4(4):265–276. doi:10.1097/00125480-199707000-00032
   PubMedGoogle Scholar
• Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4(2):481. doi:10.2215/CJN.04800908
   PubMed Web of Science ®Google Scholar
• Small DM, Coombes JS, Bennett N, Johnson DW, Gobe GC. Oxidative stress, antioxidant therapies and chronic kidney disease. Nephrology. 2012;17(4):311–321. doi:10.1111/j.1440-1797.2012.01572.x
   PubMed Web of Science ®Google Scholar
• Wu Q, Wang X, Nepovimova E, Wang Y, Yang H, Kuca K. Mechanism of cyclosporine A nephrotoxicity: oxidative stress, autophagy, and signalings. Food Chem Toxicol. 2018;118:889–907. doi:10.1016/j.fct.2018.06.054
   PubMed Web of Science ®Google Scholar
• Jeon SH, Park HM, Kim SJ, et al. Taurine reduces FK506-induced generation of ROS and activation of JNK and bax in madin darby canine kidney cells. Hum Exp Toxicol. 2010;29(8):627–633. doi:10.1177/0960327109359019
   Web of Science ®Google Scholar
• Al-Harbi NO, Imam F, Al-Harbi MM, et al. Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue. Biomed Res Int. 2014;2014:1–7. doi:10.1155/2014/607246
   Web of Science ®Google Scholar
• Zhou X, Yang G, Davis CA, et al. Hydrogen peroxide mediates FK506-induced cytotoxicity in renal cells. Kidney Int. 2004;65(1):139–147. doi:10.1111/j.1523-1755.2004.00380.x
   Web of Science ®Google Scholar
• Han SY, Mun KC, Choi HJ, et al. Effects of cyclosporine and tacrolimus on the oxidative stress in cultured mesangial cells. Transplant Proc. 2006;38(7):2240–2241. doi:10.1016/j.transproceed.2006.06.078
   Web of Science ®Google Scholar
• Yu DY, Luo J, Bu F, Zhang W, Wei Q. Effects of cyclosporin A, FK506 and rapamycin on calcineurin phosphatase activity in mouse brain. IUBMB Life. 2006;58(7):429–433. doi:10.1080/15216540600791555
   Web of Science ®Google Scholar
• Campagne O, Mager DE, Brazeau D, Venuto RC, Tornatore KM. The impact of tacrolimus exposure on extrarenal adverse effects in adult renal transplant recipients. Br J Clin Pharmacol. 2019;85(3):516–529. doi:10.1111/bcp.13811
   PubMed Web of Science ®Google Scholar
• Tumlin JA. Expression and function of calcineurin in the mammalian nephron: physiological roles, receptor signaling, and ion transport. Am J Kidney Dis. 1997;30(6):884–895. doi:10.1016/S0272-6386(97)90100-1
   Web of Science ®Google Scholar
• DiJoseph JF, Sharma RN, Chang JY. The effect of rapamycin on kidney function in the sprague-dawley rat. Transplantation. 1992;53(3):507–513. doi:10.1097/00007890-199203000-00002
   Web of Science ®Google Scholar
• Musson REA, Cobbaert CM, Smit NPM. Molecular diagnostics of calcineurin-related pathologies. Clin Chem. 2012;58(3):511–522. doi:10.1373/clinchem.2011.167296
   Web of Science ®Google Scholar
• Gooch JL, Roberts BR, Cobbs SL, Tumlin JA. Loss of the alpha-isoform of calcineurin is sufficient to induce nephrotoxicity and altered expression of transforming growth factor-beta. Transplantation. 2007;83(4):439–447. doi:10.1097/01.tp.0000251423.78124.51
   Web of Science ®Google Scholar
• Damiano S, Ciarcia R, Montagnaro S, et al. Prevention of nephrotoxicity induced by cyclosporine-A: role of antioxidants. J Cell Biochem. 2015;116(3):364–369.
   PubMed Web of Science ®Google Scholar
• Seifried HE, Anderson DE, Fisher EI, Milner JA. A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem. 2007;18(9):567–579. doi:10.1016/j.jnutbio.2006.10.007
   PubMed Web of Science ®Google Scholar
• Dennis JM, Witting PK. Protective role for antioxidants in acute kidney disease. Nutrients. 2017;9:7.
   Web of Science ®Google Scholar
• Zhou X, Mester C, Stemmer PM, Reid GE. Oxidation-induced conformational changes in calcineurin determined by covalent labeling and tandem mass spectrometry. Biochemistry. 2014;53(43):6754–6765. doi:10.1021/bi5009744
   Web of Science ®Google Scholar
• Sommer D, Fakata KL, Swanson SA, Stemmer PM. Modulation of the phosphatase activity of calcineurin by oxidants and antioxidants in vitro. Eur J Biochem. 2000;267(8):2312–2322. doi:10.1046/j.1432-1327.2000.01240.x
   Google Scholar
• Wang H, Zhou CL, Lei H, Zhang SD, Zheng J, Wei Q. Kaempferol: a new immunosuppressant of calcineurin. IUBMB Life. 2008;60(8):549–554. doi:10.1002/iub.94
   Web of Science ®Google Scholar
• Wang H, Zhou CL, Lei H, Wei Q. Inhibition of calcineurin by quercetin in vitro and in jurkat cells. J Biochem. 2010;147(2):185–190. doi:10.1093/jb/mvp163
   PubMed Web of Science ®Google Scholar
• Li L, Greene I, Readhead B, et al. Novel therapeutics identification for fibrosis in renal allograft using integrative informatics approach. Sci Rep. 2017;7(1):39487. doi:10.1038/srep39487
   Web of Science ®Google Scholar